Coronavirus News Roundup: FDA Authorizes Johnson & Johnson Vaccine; Biden Pledges Vaccine Supply for All US Adults by End of May
Here's a roundup of the latest coronavirus-related news.
The COVID-19 vaccination effort is well underway in the US, with over 82.57 million administered doses and 8.3% of the population fully vaccinated against the virus as of press time.
This week, President Biden promised that the federal government will have enough doses of the COVID-19 vaccine to vaccinate approximately 300 million Americans by the end of May, and the FDA authorized the third vaccine for COVID-19.
Here’s a roundup of the latest coronavirus-related news:
IDSA: COVID-19 Testing, Masking Still Needed to Control Pandemic
In a briefing, the Infectious Diseases Society of America (IDSA) stressed the continued importance of COVID-19 control measures that have been there from the start.
Read more on Contemporary Pediatrics
Biden Pledges Enough COVID-19 Vaccines for All US Adults By End of May
President Biden promised that the federal government will have enough doses of the COVID-19 vaccine to vaccinate approximately 300 million Americans by the end of May, which is 2 months earlier than anticipated.
Shingles Vaccination Counseling During the COVID-19 Pandemic
New guidance from the CDC regarding vaccination against shingles during the COVID-19 pandemic designates it as an essential preventive care service for older adults that should not be delayed or discontinued unless a patient is suspected or confirmed to have COVID-19.
Study Results Show Half of Severe COVID-19 Patients Have Damage to the Heart
Approximately 50% of patients hospitalized for severe COVID-19 and with elevated troponin levels presented lasting heart damage, including myocarditis, infarction, ischemia, as well as combinations of all 3, according to a recent study.
FDA Updates Storage, Transportation Guidance for Pfizer-BioNTech COVID-19 Vaccine
Officials with the FDA recently announced updates to required storage and transportation conditions for the Pfizer-BioNTech COVID-19 vaccine.
FDA Grants Emergency Use Authorization to Third COVID-19 Vaccine
The FDA has granted emergency use authorization (EUA) to Johnson & Johnson for its COVID-19 vaccine.
Examining Impact of COVID-19 Diagnosis Timing on AF Progression | AHA 2024
November 21st 2024“[O]ur data do not support the hypothesis that early COVID resulted in more significant structural or electrical cardiac remodeling that would increase the likelihood of atrial fibrillation progression,” the authors said.
